Sign in

CIK 0001984086

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Septerna, Inc.

Sign in to watch
Ticker
SEPN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
843891440
Phone
+1 650-338-3533
Business address
250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,849,459
in 5 filings, $5.8M under 10b5-1 plans

Net −$5,849,459. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-16 Labrucherie Gil M Chief Financial Officer Sale 10b5-1 −15,815 $41.48 $656K 24,185
2026-11-16 Labrucherie Gil M Chief Financial Officer Sale 10b5-1 −3,485 $41.99 $146K 20,700
2026-11-16 Labrucherie Gil M Chief Financial Officer Sale 10b5-1 −700 $43.00 $30K 20,000
2026-02-06 Labrucherie Gil M Chief Financial Officer Grant or award · Stock Option (Right to Buy) +125,000 125,000
2025-08-07 Labrucherie Gil M Chief Financial Officer Grant or award · Stock Option (Right to Buy) +37,500 37,500
2025-02-27 Labrucherie Gil M Chief Financial Officer Purchase +3,718 $5.85 $22K 40,000
2025-02-25 Labrucherie Gil M Chief Financial Officer Purchase +6,282 $5.59 $35K 36,282
2025-02-21 Labrucherie Gil M Chief Financial Officer Purchase +5,000 $5.85 $29K 30,000
2025-02-20 Labrucherie Gil M Chief Financial Officer Purchase +14,500 $5.88 $85K 25,000
2025-02-19 Labrucherie Gil M Chief Financial Officer Purchase +10,500 $5.51 $58K 10,500
2025-02-07 Labrucherie Gil M Chief Financial Officer Grant or award · Stock Option (Right to Buy) +222,000 222,000

Page 1 of 1 · 11 trades